Kaiko Systems | $6,512,218 | (Mar 21, 2025)
257 | $9,200,000 | (Mar 21, 2025)
Moonwatt | $8,000,000 | (Mar 21, 2025)
Certified by Founder
Lodge
DISCO Pharmaceuticals GmbH
start up
Germany
- Cologne, North Rhine-Westphalia
- 17/01/2024
- Seed
- $21,727,000
DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies. These insights enable the development of a multitude of cancer-selective therapies, with the potential to boost efficacy and reducing side effects for patients.
- Industry Pharmaceutical Manufacturing
- Website https://discopharma.de/
- LinkedIn https://www.linkedin.com/company/disco-pharmaceuticals-gmbh/about/
Kyberlife | $3,000,000 | (Mar 21, 2025)
PlaysOut | $7,000,000 | (Mar 21, 2025)
Coreshell | $24,000,000 | (Mar 21, 2025)
PULSETRAIN | $6,621,186 | (Mar 21, 2025)
Utila | $18,000,000 | (Mar 21, 2025)
Ownright | $4,500,000 | (Mar 21, 2025)
LimitlessCNC | $4,100,000 | (Mar 21, 2025)
Decibel Bio | $12,000,000 | (Mar 21, 2025)
CaseBlink | $2,000,000 | (Mar 21, 2025)